Table 2.

Subgroup analysis of MALAT1 in serum as a biomarker for non‐small cell lung cancer (NSCLC) diagnosis according to pathology type

Diagnostic reference	Squamous cell carcinoma	Chi‐square/Cochran‐Q	P‐value	Adenocarcinoma	Chi‐square	P‐value
Sen	0.74 (0.60–0.85)	10.10	0.0015	0.62 (0.48–0.75)	8.13	0.0043
Sep	0.87 (0.78–0.93)	8.33	0.0039	0.88 (0.79–0.94)	7.51	0.0061
+LR	8.01 (1.36–47.31)	2.01	0.156	5.44 (2.01–14.70)	1.19	0.2760
−LR	0.23 (0.03–1.84)	9.10	0.0027	0.43 (0.17–1.10)	7.10	0.0077
DOR	54.86 (13.65–220.43)	0.00	0.9453	17.55 (6.57–46.89)	0.20	0.6583